- Home
- MIST vs MED Comparison
MIST vs MED Comparison
Compare MIST & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | MED |
|---|---|---|
| Founded | 2003 | 1980 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.3M | 122.8M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MIST | MED |
|---|---|---|
| Price | $1.04 | $12.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $8.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.7M | 171.2K |
| Earning Date | 05-13-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $934,842,000.00 |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $9.22 |
| 52 Week High | $3.06 | $14.67 |
Technical Indicators
Market Signals| Indicator | MIST | MED |
|---|---|---|
| Relative Strength Index (RSI) | 39.32 | 59.44 |
| Support Level | $1.01 | $9.84 |
| Resistance Level | $1.42 | $12.21 |
| Average True Range (ATR) | 0.07 | 0.48 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 7.41 | 37.14 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.